Triptorelin — Drug Intelligence | 32 EU Trials

Filter these 32 trials by condition, phase, country and more.

Open in Search →

32 Registered trials

13 Recruiting

11 Completed trials

19 Sponsors

19 Countries

Phase III

Phase II

Phase IV

Phase III: 16 Phase II/III: 1 Phase II: 6 Phase I/II: 1 Phase III/IV: 1 Phase IV: 7

Oversight events:

1 temporary halt 2 unexpected events across 2 trials

View oversight register →

Indications tested

Prostate cancer 2 Infertility 2 Assisted reproductive technology 1 Infertility female 1 Breast cancer metastatic 1

Sponsors using this IMP

Santiago Dexeus Font Fundacio Privada 6 Unicancer 5 Instituto Bernabeu S.L. 3 AstraZeneca AB 2 Ziekenhuis Aan De Stroom 2 Alliance Foundation Trials LLC 1 Assistance Publique Hopitaux De Paris 1 Azienda Provinciale Per I Servizi Sanitari 1 Azienda Socio Sanitaria Territoriale Degli Spedali Civili Di Brescia 1 Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) 1 ETOP IBCSG Partners Foundation 1 Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europeenne Pour La Recherche Et Le Traitement Du Cancer European Organi 1

All trials — page 2

32 total

A phase II, randomized, open-label study comparing salvage radiotherapy in combination with 6 months of androgen-deprivation therapy (ADT) w… Ended

2024-512023-37-00 Phase II 1 country Ziekenhuis Aan De Stroom
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine-Based Therapy Ended

2022-501024-20-00 Phase III 14 countries Astrazeneca AB
DARIUS : A randomized non-comparative phase II multicentric trial on short term DARolutamide (ODM-201) concomitant to radiation therapy for … Ended

2023-509494-23-00 Phase II 1 country Institut Bergonie
A research study to compare the standard treatment and the study drug (degarelix) in combination with radiotherapy in patients with high-ris… Ended

2024-513450-30-00 Phase III 3 countries Europese Organisatie Voor Onderzoek En Behandeling Van Kanker Organisation Europ…
The impact of the intensity of ovarian stimulation on embryo quality in predicted suboptimal responders. A randomized controlled trial. Ended

2024-514322-23-00 Phase IV 1 country Santiago Dexeus Font Fundacio Privada
A Window-of-Opportunity study of hormone therapy in premenopausal women with ER-positive/HER2-negative early breast cancer. Ended

2022-503013-32-00 Phase II 7 countries ETOP IBCSG Partners Foundation
A randomized controlled trial comparing sequential of two shots of CFA vs CFA + rFSH for Elective Fertility Preservation. The 2-shot protoco… Ended

2023-506162-31-00 Phase III 1 country Santiago Dexeus Font Fundacio Privada
Detection of tumor DNA in the blood of patients receiving standard therapy for hormone receptorpositive (HR+) non-HER2 expressing (HER2-) me… Ended

2022-502372-22-01 Phase II 1 country Unicancer

Showing 25–32 of 32 trials

← All drugs A–Z